Inventor
MORRIELLO GREGORI J
US23 patents
⚠️ This page may combine multiple inventors who share the name “MORRIELLO GREGORI J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
7 patentsUS5494919AFeb 27, 1996
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC104 citations98
US5721250AFeb 24, 1998
Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC86 citations96
US5492916AFeb 20, 1996
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC96 citations96
US6121325ASep 19, 2000
Naphthyl compounds promote release of growth hormone
MERCK & CO INC33 citations92
US5663171ASep 2, 1997
Acyclic compounds promote release of growth hormone
MERCK & CO INC45 citations92
US5622973AApr 22, 1997
Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates
MERCK & CO INC46 citations92
US7704988B2Apr 27, 2010
Anti-hypercholesterolemic compounds
MERCK & CO INC0 citations42
MERCK SHARP & DOHME
5 patentsUS9018224B2Apr 28, 2015
Substituted cyclopropyl compounds useful as GPR119 agonists
MERCK SHARP & DOHME1 citations51
US10138255B2Nov 27, 2018
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations50
US9840478B2Dec 12, 2017
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations48
US10647727B2May 12, 2020
Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
MERCK SHARP & DOHME0 citations39
US10357481B2Jul 23, 2019
Substituted triazolo bicyclic compounds as PDE2 inhibitors
MERCK SHARP & DOHME0 citations39
BERGER RICHARD
4 patentsUS8247415B2Aug 21, 2012
Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
BERGER RICHARD40 citations97
US8399480B2Mar 19, 2013
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD36 citations93
US8653260B2Feb 18, 2014
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD18 citations92
US8501786B2Aug 6, 2013
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD0 citations40
MERCK SHARP & DOHME LLC
4 patentsUS12030872B2Jul 9, 2024
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC2 citations69
US12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12570640B2Mar 10, 2026
2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations46
US12540131B2Feb 3, 2026
N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations42